Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Oncol Rep ; 41(5): 2615-2624, 2019 May.
Article in English | MEDLINE | ID: mdl-30896830

ABSTRACT

Head and neck squamous cell carcinoma (HNSCC) is the sixth most commonly diagnosed cancer worldwide. It has poor clinical outcome due to intrinsic or acquired drug resistance. Deregulation of both apoptosis and autophagy contributes to chemotherapy resistance and disease progression. A new member of the inhibitors of apoptosis protein (IAP) family, namely survivin, is selectively overexpressed in tumors, including HNSCC, but not in normal tissues. Thus, it is considered a tumor biomarker. Here, we reviewed survivin expression and function in tumor progression focusing on its nodal role in the regulation of cell apoptosis and autophagy. Based on literature data, survivin targeting may be envisaged as a novel therapeutic strategy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Biomarkers, Tumor/metabolism , Head and Neck Neoplasms/drug therapy , Squamous Cell Carcinoma of Head and Neck/drug therapy , Survivin/metabolism , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Apoptosis/drug effects , Autophagy/drug effects , Biomarkers, Tumor/antagonists & inhibitors , Cell Cycle/drug effects , Clinical Trials as Topic , Disease Progression , Drug Resistance, Neoplasm/drug effects , Head and Neck Neoplasms/pathology , Humans , Molecular Targeted Therapy/methods , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/prevention & control , Squamous Cell Carcinoma of Head and Neck/pathology , Survivin/antagonists & inhibitors , Treatment Outcome
2.
Leukemia ; 30(3): 640-8, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26487273

ABSTRACT

Bortezomib (bort) has improved overall survival in patients with multiple myeloma (MM), but the majority of them develop drug resistance. In this study, we demonstrate that bone marrow (BM) fibroblasts (cancer-associated fibroblasts; CAFs) from bort-resistant patients are insensitive to bort and protect the RPMI8226 and patients' plasma cells against bort-induced apoptosis. Bort triggers CAFs to produce high levels of interleukin (IL)-6, IL-8, insulin-like growth factor (IGF)-1 and transforming growth factor (TGF) ß. Proteomic studies on CAFs demonstrate that bort resistance parallels activation of oxidative stress and pro-survival autophagy. Indeed, bort induces reactive oxygen species in bort-resistant CAFs and activates autophagy by increasing light chain 3 protein (LC3)-II and inhibiting p62 and phospho-mammalian target of rapamycin. The small-interfering RNA knockdown of Atg7, and treatment with 3-methyladenine, restores bort sensitivity in bort-resistant CAFs and produces cytotoxicity in plasma cells co-cultured with CAFs. In the syngeneic 5T33 MM model, bort-treatment induces the expansion of LC3-II(+) CAFs. TGFß mediates bort-induced autophagy, and its blockade by LY2109761, a selective TßRI/II inhibitor, reduces the expression of p-Smad2/3 and LC3-II and induces apoptosis in bort-resistant CAFs. A combination of bort and LY2109761 synergistically induces apoptosis of RPMI8226 co-cultured with bort-resistant CAFs. These data define a key role for CAFs in bort resistance of plasma cells and provide the basis for a novel targeted therapeutic approach.


Subject(s)
Antineoplastic Agents/pharmacology , Bortezomib/pharmacology , Drug Resistance, Neoplasm/drug effects , Gene Expression Regulation, Neoplastic , Multiple Myeloma/drug therapy , Pyrazoles/pharmacology , Pyrroles/pharmacology , Transforming Growth Factor beta/antagonists & inhibitors , Aged , Aged, 80 and over , Animals , Autophagy/drug effects , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Drug Combinations , Drug Resistance, Neoplasm/genetics , Female , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Humans , Male , Mice , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Middle Aged , Multiple Myeloma/genetics , Multiple Myeloma/mortality , Multiple Myeloma/pathology , Plasma Cells/drug effects , Plasma Cells/metabolism , Plasma Cells/pathology , Primary Cell Culture , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Signal Transduction , Survival Analysis , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/metabolism , Xenograft Model Antitumor Assays
3.
Leukemia ; 28(4): 904-16, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23995611

ABSTRACT

The role of cancer-associated fibroblasts (CAFs) has not been previously studied in multiple myeloma (MM). Here, cytofluorimetric analysis revealed higher proportions of bone marrow (BM) CAFs in patients with active MM (both at diagnosis and relapse) compared with patients in remission or those with monoclonal gammopathy of undetermined significance or deficiency anemia (controls). CAFs from MM patients produced increased levels of transforming growth factor-ß, interleukin-6, stromal cell-derived factor-1α, insulin-like growth factor-1, vascular endothelial growth factor and fibroblast growth factor-2 and displayed an activated and heterogeneous phenotype, which supported their origin from resident fibroblasts, endothelial cells and hematopoietic stem and progenitor cells via the endothelial-mesenchymal transition as well as mesenchymal stem cells via the mesenchymal transition, as both of these processes are induced by MM cells and CAFs. Active MM CAFs fostered chemotaxis, adhesion, proliferation and apoptosis resistance in MM cells through cytokine signals and cell-to-cell contact, which were inhibited by blocking CXCR4, several integrins and fibronectin. MM cells also induced the CAFs proliferation. In syngeneic 5T33MM and xenograft mouse models, MM cells induced the expansion of CAFs, which, in turn, promoted MM initiation and progression as well as angiogenesis. In BM biopsies from patients and mice, nests of CAFs were found in close contact with MM cells, suggesting a supportive niche. Therefore, the targeting of CAFs in MM patients may be envisaged as a novel therapeutic strategy.


Subject(s)
Bone Marrow Cells/physiology , Fibroblasts/physiology , Multiple Myeloma/pathology , Aged , Aged, 80 and over , Animals , Apoptosis , Cell Proliferation , Cells, Cultured , Chemokine CXCL12/physiology , Disease Progression , Epithelial-Mesenchymal Transition , Female , Humans , Male , Mice , Mice, Inbred C57BL , Middle Aged , Phenotype
4.
Int J Immunopathol Pharmacol ; 22(2): 485-92, 2009.
Article in English | MEDLINE | ID: mdl-19505400

ABSTRACT

Fibroblasts play a key role in tissue healing by producing the majority of extracellular matrix components, favouring granulation tissue formation, and stimulating re-epithelialization. Hyaluronan is a component of ECM and its anti-inflammatory effects and properties in enhancing wound closure are well known. In this study, we examined the effects of Aminogam gel, a new pharmacological preparation suggested to improve wound healing, composed of hyaluronic acid, proline, lysine, glycine and leucine, on human fibroblasts. Results show that fibroblasts treated with hyaluronic acid plus aminoacid solution increased their proliferative activity, collagen I and III, and fibronectin synthesis. Moreover, HA plus aminoacid solution increased the expression of transforming growth factor beta, connective tissue growth factor, interleukin-6 and -8, assayed by RT-PCR. These results suggested that Aminogam gel, involved in several stages of wound healing, as fibroblast proliferation, granulation tissue formation, ECM component deposition, and production of cytokines, may be a useful device to favour and accelerate wound closure.


Subject(s)
Amino Acids/pharmacology , Cell Proliferation/drug effects , Collagen Type III/biosynthesis , Collagen Type I/biosynthesis , Fibroblasts/drug effects , Hyaluronic Acid/pharmacology , Intercellular Signaling Peptides and Proteins/metabolism , Wound Healing/drug effects , Cell Cycle/drug effects , Cells, Cultured , Collagen Type I/genetics , Collagen Type III/genetics , Connective Tissue Growth Factor/metabolism , Drug Combinations , Fibroblasts/metabolism , Fibronectins/biosynthesis , Humans , Intercellular Signaling Peptides and Proteins/genetics , Interleukin-6/metabolism , Interleukin-8/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transforming Growth Factor beta/metabolism
5.
Int J Immunopathol Pharmacol ; 18(3 Suppl): 33-8, 2005.
Article in English | MEDLINE | ID: mdl-16848985

ABSTRACT

The molecular mechanisms involved in the development of oral squamous cell carcinomas (OSCC) are not yet well understood. Evidence of recent studies suggests that aberrant beta-catenin signalling may participate in the neoplastic transformation and that it is implicated in the development of several tumours. Beta-catenin is a component of the catenin family and plays a crucial role in cadherin mediated cell adhesion. However, it has recently been shown that beta-catenin is also involved in other functions such as intracellular signalling and the regulation of gene transcription. The aim of this study is to evaluate the presence of mutation in exon 3 of the beta-catenin gene in 20 OSCC cell lines. DNA was extracted using Qiagen Qiamp DNA minikit and a region encompassing the exon 3 of beta-catenin gene was amplified using a single PCR assay. The PCR products were analysed by SSCP and direct sequencing to detect any mutation of the gene. Most of the cell lines examined showed, by immunofluorescence, a beta-catenin delocalization. SSCP and sequence analysis of the PCR products did not show any mutation of the beta-catenin gene in any of the cell lines. In conclusion, although aberrant expressions or abnormal localization of beta-catenin have been detected in several OSCC cells, it appears that this finding has no relationship with beta-catenin gene mutations.


Subject(s)
Carcinoma, Squamous Cell/genetics , Mouth Neoplasms/genetics , Mutation , beta Catenin/genetics , Cell Line, Tumor , Exons , Humans
6.
J Periodontal Res ; 36(1): 32-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11246702

ABSTRACT

Apoptosis provides a mechanism for clearance of unwanted cells in a variety of situations in which programmed or physiological cell death occurs; but the premature death of defensive cells could promote infection, inflammation and concomitant disease. We detected high values of apoptosis in polymorphonuclear cells (PMN) elicited from crevicular sulci of smokers affected by adult periodontitis. To learn more about the effects of nicotine on the periodontal environment, we studied its ability to modulate the apoptosis of two phagocytic lines, PMN and mononuclear cells, which are continuously recruited from gingival vessels to prevent or control plaque extension. Brief exposure of PMN to nicotine concentrations ranging from 0.01 to 0.3% shortened, in a dose-dependent relationship, the lag culture time required to observe at fluorescent microscopy the morphological traces of apoptosis. These observations were confirmed by specific tools of apoptosis: DNA fragmentation on gel electrophoresis and expression of the apoptosis-signaling receptor Fas/Apo-1. The apoptotic effect excited by nicotine on these first line defensive cells may be an important feature of the pathogenesis of periodontal disease. As for mononuclear leukocytes, nicotine was unable to induce apoptotic modifications on cells observed up to 72 h culture time, but the drug inhibited IL-1beta release and procoagulant activity (PCA) expression. The conflicting role played by these lipopolysaccharide (LPS)-induced monocyte functions in the inflammatory process is a further intrigue in the mechanism by which nicotine compromises the oral health.


Subject(s)
Apoptosis/drug effects , Neutrophils/drug effects , Nicotine/pharmacology , Periodontitis/immunology , Case-Control Studies , Female , Gingival Crevicular Fluid/cytology , Humans , Interleukin-1/biosynthesis , Leukocytes, Mononuclear/drug effects , Lipopolysaccharides/pharmacology , Male , Microscopy, Fluorescence , Middle Aged , Monocytes/drug effects , Monocytes/metabolism , Neutrophils/metabolism , Thromboplastin/biosynthesis
7.
Immunopharmacol Immunotoxicol ; 20(3): 399-408, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9736444

ABSTRACT

Hydrogen sulfide is a toxic metabolite released by several bacterial agents under anaerobic conditions. In the present paper, we investigated the effects of sulfide on polymorphonuclear cell (PMN) apoptosis, a mechanism suggested for limiting the toxic potential of neutrophils in inflammatory sites. We showed that 1 mM sulfide (concentration not conditioning PMN viability) is able to enhance the apoptotic fate of human granulocytes by increasing: i) the number of cells containing pyknotic nuclei, ii) the internucleosomal cleavage, and, iii) the intensity of tubulin immunofluorescence staining. The sulfide effect is partially prevented by ionomycin and this finding is consistent with the hypothesis of the inhibiting role played by high levels of cytosolic calcium in PMN apoptosis modulating.


Subject(s)
Apoptosis/drug effects , Neutrophils/drug effects , Sulfides/toxicity , Calcium/metabolism , Humans , Neutrophils/physiology , Tubulin/analysis
8.
Immunopharmacol Immunotoxicol ; 19(3): 393-404, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9248866

ABSTRACT

Polymorphonuclear cells (PMN) of gingival sulcus play an important role in host defense against periodontal tissue-invading bacteria, but their phagocytic activity is conditioned by several virulence factors released by oral pathogens. In this report we have studied the influence of sulfide, a toxic bacterial metabolite, on the main PMN functions: chemotaxis, degranulation and oxidative burst. PMN exposed to sodium sulfide (up to 2 mM) used as a source of H2S showed a depression of the calcium-dependent cytoskeleton activities such as chemotaxis and azurophilic granule release induced by FMLP. No effect was observed on the calcium-independent specific granule release obtained by PMA. These data were in agreement with the sulfide inhibition of cytosolic free Ca2+ concentration [Ca2+]i increase normally induced by ionomycin. On the other hand, hydrogen sulfide was able to prime PMN for a stronger oxidative response both to calcium-dependent or calcium-independent stimulation. This finding may account for a more efficient oxidative killing under reoxygenation of the anaerobic infectious areas.


Subject(s)
Calcium/physiology , Neutrophils/drug effects , Sulfides/pharmacology , Cell Degranulation/drug effects , Cell Degranulation/immunology , Chemotaxis, Leukocyte/drug effects , Chemotaxis, Leukocyte/immunology , Humans , Neutrophils/immunology , Respiratory Burst/drug effects , Respiratory Burst/immunology , Saccharomyces cerevisiae
10.
Immunopharmacol Immunotoxicol ; 16(3): 449-61, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7528238

ABSTRACT

Intracellular pathogens have evolved effective mechanisms in order to survive in an intracellular environment, thus avoiding destruction by phagocytic cells. In this regard, a correlation between resistance to phagocytic killing and expression of pathogenic potency has been established. In this report, we have studied the interaction between human polymorphonuclear cells (PMN) and two gram-negative microorganisms, Afipia felis and Rochalimaea henselae, which belong to the alpha-2 subgroup of the class Proteobacteria. A. falis has been previously proposed as the causative agent of Cat Scratch Disease (CSD), but several recent lines of evidence attribute a major role to R. henselae. Of note, CSD is a syndrome characterized by a chronic lymphoadenopathy, involving macrophages and endothelial cells with a progression towards a granulomatous process and/or angiogenesis. Since members of the alpha-2 subgroup of Proteobacteria have the property to survive intracellularly, we have evaluated the effects exerted by A. felis and R. henselae on human PMN in terms of chemotaxis locomotion, degranulation and oxidative metabolism. Results will show an impairment of PMN activities as a consequence of the challenge with both microrganisms. In particular, inhibition of PMN oxidative function occurred either as result of a direct exposure to both A. felis and R. henselae or when PMN were primed by bacteria for the N-formyl-methionyl-leucyl-phenylalanine enhancement of the oxidative burst. These findings may account for the ability of A. felis and R. henselae to survive within PMN as expression of a further mechanism of pathogenic potency, influencing also the nature and the evolution of inflammatory response in the lesion sites.


Subject(s)
Bartonella henselae/immunology , Gram-Negative Bacteria/immunology , Neutrophils/microbiology , Cat-Scratch Disease/microbiology , Cell Degranulation/physiology , Chemotaxis, Leukocyte/physiology , Down-Regulation/immunology , Humans , In Vitro Techniques , Luminescent Measurements , Neutrophils/immunology , Reactive Oxygen Species/metabolism , Zymosan/pharmacology
11.
Oral Microbiol Immunol ; 8(2): 125-7, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8355986

ABSTRACT

Respiratory burst, enzymatic degranulation and bacterial killing were investigated on peripheral blood polymorphonuclear leukocytes (polymorphonuclear leukocytes) incubated with a pool of salivary fluids elicited from healthy donors. Low saliva concentrations primed polymorphonuclear leukocytes for enhancement of O2 consumption, O2- and beta-glucuronidase release and Staphylococcus aureus killing. Whole saliva, on the contrary, depressed all tested phagocytic activities.


Subject(s)
Neutrophils/physiology , Saliva/physiology , Adult , Glucuronidase/metabolism , Humans , Neutrophils/metabolism , Oxygen Consumption , Phagocytosis/physiology , Respiratory Burst , Saliva/enzymology
12.
Thromb Haemost ; 66(6): 662-5, 1991 Dec 02.
Article in English | MEDLINE | ID: mdl-1796411

ABSTRACT

Retinoids are known to modulate several functions of mononuclear phagocytes. We have studied the effect of retinyl acetate (RAc) and retinoic acid (RA) on the production of procoagulant activity (PCA) by human peripheral blood mononuclear cells stimulated with endotoxin (1 microgram/ml, 4 or 20 h at 37 degrees C). Both compounds caused a dose-dependent reduction in the expression of cell-associated PCA (from 86 to less than 10% of control in the range of concentration comprised between 0.1 and 100 microM). This effect was also observed when the cells were exposed to retinoids for 10 min and washed before challenge with endotoxin, indicating that it is rapid and irreversible. In contrast, incubation of RAc or RA for 3 h at 37 degrees C with cells that have been already stimulated with endotoxin (20 h at 37 degrees C) remained without influence on cell PCA. The inhibitory action of retinoids was also observed when monocyte-enriched (greater than 85%) preparations or highly purified monocyte-derived macrophages (greater than 99%) were used instead of whole mononuclear cells. BW755C, an inhibitor of cyclo-oxygenase and lipoxygenase, reversed the inhibitory effect of retinoids, whereas acetylsalycilic acid, an inhibitor of cyclo-oxygenase, was inactive, suggesting the involvement of a lipoxygenase product. The inhibition of monocyte/macrophage PCA production and the subsequent reduction of cell potential for fibrin deposition might represent one of the mechanisms whereby retinoids exert their antiinflammatory and immunomodulatory activities.


Subject(s)
Blood Coagulation/drug effects , Leukocytes, Mononuclear/drug effects , Phagocytes/drug effects , Tretinoin/pharmacology , Vitamin A/analogs & derivatives , Diterpenes , Humans , In Vitro Techniques , Retinyl Esters , Vitamin A/pharmacology
13.
Agents Actions ; 34(3-4): 339-44, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1667243

ABSTRACT

Retinoids exhibit a wide spectrum of activities, including antiinflammatory properties. We have investigated the effect of retinoic acid (RA) and retinyl acetate (RAc) on the production of reactive oxygen metabolites and the release of lysosomal enzymes by human polymorphonuclear leukocytes (PMN). Incubation of PMN with RAc or RA (1-100 microM) caused a dose-dependent inhibition (upto 90%) in O2- production and chemiluminescence induced by phorbol myristate acetate (PMA), N-formyl-methionyl-leucyl-phenylanaline (fMLP), opsonized zymosan or ionophore A23187. Both retinoids (1-100 microM) also inhibited, in a dose-dependent way, degranulation induced by fMLP (upto 85% at the highest concentration of RA). These inhibitory effects appear irreversible, since they persist after the drugs are removed and the cells washed before stimulation. Inhibitors of cyclo-oxygenase activity such as acetylsalicyclic acid and indomethacin did not influence the effects of RAc. In contrast, BW755, an inhibitor of both cyclooxygenase and lipoxygenase, reversed the inhibitory action of RAc, suggesting that the effect of retinoids occurs possibly through the mediation of lipoxygenase products. The modulation of PMN oxidative metabolism and degranulation might help explain the antiinflammatory properties of retinoids.


Subject(s)
Cytoplasmic Granules/physiology , Neutrophils/physiology , Respiratory Burst/drug effects , Tretinoin/pharmacology , Vitamin A/analogs & derivatives , Calcimycin/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Cytoplasmic Granules/drug effects , Diterpenes , Humans , Lipoxygenase Inhibitors/pharmacology , Luminescent Measurements , Lysosomes/enzymology , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/drug effects , Neutrophils/ultrastructure , Retinyl Esters , Superoxides/blood , Tetradecanoylphorbol Acetate/pharmacology , Vitamin A/pharmacology , Zymosan/pharmacology
14.
Acta Virol ; 34(6): 517-22, 1990 Dec.
Article in English | MEDLINE | ID: mdl-1983177

ABSTRACT

The effect of scrapie prion protein (PrP) either in the native or in the denatured form was studied on in vitro responses of human neutrophils. Incubation of neutrophils with native PrP caused an inhibition of their aggregation induced by cytochalasin B. Moreover, the denatured form was in itself a strong aggregation inducer. When evaluating the effect on generation of neutrophil superoxide anion (O2) we found that neutrophils released O2 in response to the denatured from only but the native form was ineffective. Similarly, neutrophil discharge of beta-glucuronidase which represents the azurophilic granule marker was stimulated in a dose-dependent form by the denatured PrP 27-30 whereas the native form was almost completely devoid of any activity. These results indicate that several aspects of neutrophil function can be altered by the native form of prion protein PrP 27-30. This might be responsible for the impaired phagocytic cell activity explaining, at least in part, the absence of any inflammatory reaction during scrapie infection.


Subject(s)
Cell Degranulation , Neutrophils/physiology , Prions/physiology , Superoxides/blood , Viral Proteins/pharmacology , Cell Aggregation , Humans , Neutrophils/enzymology , Neutrophils/microbiology , PrP 27-30 Protein
15.
Microbiologica ; 12(1): 55-60, 1989 Jan.
Article in English | MEDLINE | ID: mdl-2541318

ABSTRACT

Human neutrophils produce small amounts of superoxide anion when stimulated with the chemotactic peptide FMLP; preincubating neutrophils with low concentrations of lipopolysaccharides (LPS) markedly increases this response, an effect referred to as priming. In this work LPS from Coxiella burnetii either phase I (virulent) or phase II (avirulent) were examined for their ability to induce priming. Results clearly show that only LPS from phase II microorganism was able to increase the release from neutrophils upon subsequent stimulation with FMLP. This effect was abolished by preincubation of LPS with polymyxin B. This finding may account for the ability of Coxiella burnetii phase I to escape intracellular phagocyte killing during persistent infections.


Subject(s)
Coxiella/metabolism , Lipopolysaccharides/metabolism , Neutrophils/metabolism , Superoxides/metabolism , Coxiella/immunology , Humans , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/drug effects
16.
Int J Tissue React ; 11(1): 21-5, 1989.
Article in English | MEDLINE | ID: mdl-2553636

ABSTRACT

Thymomodulin is an immunomodulating agent which is derived from calf thymus by partial acid lysis. It promotes T-cell maturation, enhances antibody synthesis and improves the phagocytic response of neutrophils. Clinical trials have revealed the effectiveness of this thymic derivative in the prevention of recurrent respiratory infections (RRI) in children and in adults; 11 patients (8 males and 3 females; age range 18-76 years) with chronic bronchitis dominated by recurrent respiratory infections were studied. They were treated orally for 6 months during the winter season with 120 mg/day of thymomodulin. All the subjects were asked to keep a diary recording the intensity of their symptoms, the number of working days lost (days of illness) and the use of antibiotic and/or mucolytic drugs. At the beginning and at the end of the trial each patient was subjected to a control with a flexible fibreoptic bronchoscope with bronchoalveolar lavage to evaluate the phagocytic response of alveolar macrophages. At the end of therapy a significant improvement of the clinical status, evaluated by the above-mentioned parameters, of the bronchial mucosa aspect and an increase in alveolar macrophage superoxide production was noticed (from 0.1 +/- 0.09 and 0.8 +/- 0.5 nmol to 1.6 +/- 0.8 and 4.1 +/- 2.2 nmol with PMA or zymosan particles respectively; p less than 0.001). During thymomodulin treatment no side-effects were recorded.


Subject(s)
Anions/metabolism , Bronchitis/metabolism , Macrophages/metabolism , Superoxides/metabolism , Thymus Extracts/pharmacology , Adolescent , Adult , Aged , Anions/analysis , Bronchitis/pathology , Bronchoalveolar Lavage Fluid/analysis , Bronchoscopy , Chronic Disease , Female , Humans , Macrophages/analysis , Male , Middle Aged , Superoxides/analysis
20.
Scand J Haematol ; 37(4): 333-6, 1986 Oct.
Article in English | MEDLINE | ID: mdl-3787183

ABSTRACT

Chronic granulomatous disease (CGD), an immunodeficiency syndrome characterized by extreme susceptibility to bacterial infections, is due to a defect of the respiratory burst in human phagocytes. NADPH oxidase, the enzyme that catalyzes the reduction of oxygen and the release of oxidative radicals, was studied in polymorphonuclear leucocytes (PMNs) in a family affected by an x-linked inheritance form at high penetrance of the disease. The contents of cytochrome b, suggested as the terminal component of the oxidase electron transport chain, and FAD, the hypothetical proximal component of the chain, were determined in patients and in carriers. Cytochrome b showed the typical behaviour of x-linked CGD: total absence in patients, intermediate values in carriers. FAD content evaluated on plasma membranes was less decreased than cytochrome b. Carriers also showed a decrease of this flavoprotein. Cytochrome b and FAD contents were compared to NBT test and superoxide production: a clear correlation was observed for the cytochrome b, but FAD plasma membrane evaluation could also be an interesting tool for the metabolic characterization of the disease in patients and in carriers.


Subject(s)
Cytochrome b Group/blood , Flavin-Adenine Dinucleotide/blood , Genetic Linkage , Granulomatous Disease, Chronic/blood , Neutrophils/metabolism , X Chromosome , Adult , Child , Female , Granulomatous Disease, Chronic/genetics , Humans , Infant , Male , NADH, NADPH Oxidoreductases/blood , NADPH Oxidases , Neutrophils/drug effects , Nitroblue Tetrazolium/metabolism , Oxidation-Reduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...